| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.07 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.052 | 0.08 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.08 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.089 | 0.08 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.08 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.08 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.08 |